Targeting WEE1 kinase as a p53-independent therapeutic strategy in high-risk and relapsed acute lymphoblastic leukemia

被引：0
|
作者：
Hayden L. Bell
Helen J. Blair
Mankaran Singh
Anthony V. Moorman
Olaf Heidenreich
Frederik W. van Delft
John Lunec
Julie A. E. Irving
机构：
[1] Newcastle University Centre for Cancer,Wolfson Childhood Cancer Research Centre, Translation and Clinical Research Institute
[2] ,undefined
[3] Princess Máxima Center for Pediatric Oncology,undefined
[4] Bioscience Institute,undefined
[5] Newcastle University Centre for Cancer,undefined
来源：
Cancer Cell International | / 23卷
关键词：
WEE1; Inhibitors; Leukemia; High-risk; Relapse; Translational; Cell cycle checkpoints;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
相关论文
共 50 条
  • [1] Targeting WEE1 kinase as a p53-independent therapeutic strategy in high-risk and relapsed acute lymphoblastic leukemia
    Bell, Hayden L.
    Blair, Helen J.
    Singh, Mankaran
    Moorman, Anthony V.
    Heidenreich, Olaf
    van Delft, Frederik W.
    Lunec, John
    Irving, Julie A. E.
    CANCER CELL INTERNATIONAL, 2023, 23 (01)
  • [2] Targeting WEE1 to enhance conventional therapies for acute lymphoblastic leukemia
    Di Rora, Andrea Ghelli Luserna
    Beeharry, Neil
    Imbrogno, Enrica
    Ferrari, Anna
    Robustelli, Valentina
    Righi, Simona
    Sabattini, Elena
    Falzacappa, Maria Vittoria Verga
    Ronchini, Chiara
    Testoni, Nicoletta
    Baldazzi, Carmen
    Papayannidis, Cristina
    Abbenante, Maria Chiara
    Marconi, Giovanni
    Paolini, Stefania
    Parisi, Sarah
    Sartor, Chiara
    Fontana, Maria Chiara
    De Matteis, Serena
    Iacobucci, Ilaria
    Pelicci, Pier Giuseppe
    Cavo, Michele
    Yen, Timothy J.
    Martinelli, Giovanni
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2018, 11
  • [3] Targeting WEE1 to enhance conventional therapies for acute lymphoblastic leukemia
    Andrea Ghelli Luserna Di Rorà
    Neil Beeharry
    Enrica Imbrogno
    Anna Ferrari
    Valentina Robustelli
    Simona Righi
    Elena Sabattini
    Maria Vittoria Verga Falzacappa
    Chiara Ronchini
    Nicoletta Testoni
    Carmen Baldazzi
    Cristina Papayannidis
    Maria Chiara Abbenante
    Giovanni Marconi
    Stefania Paolini
    Sarah Parisi
    Chiara Sartor
    Maria Chiara Fontana
    Serena De Matteis
    Ilaria Iacobucci
    Pier Giuseppe Pelicci
    Michele Cavo
    Timothy J. Yen
    Giovanni Martinelli
    Journal of Hematology & Oncology, 11
  • [4] Targeting Mutant p53 in Acute Lymphoblastic Leukemia as a Novel Therapeutic Strategy
    Demir, S.
    Sun, Q.
    Tausch, E.
    Stilgenbauer, S.
    Kronnie, G. te
    Wiesmueller, L.
    Selivanova, G.
    Debatin, K-M
    Meyer, L. H.
    ANNALS OF HEMATOLOGY, 2017, 96 : S73 - S73
  • [5] Combination p53 activation and BCL-xL/BCL-2 inhibition as a therapeutic strategy in high-risk and relapsed acute lymphoblastic leukemia
    Bell, Hayden L.
    Blair, Helen J.
    Gosling, Samantha J. Jepson
    Galler, Martin
    Astley, Daniel
    Moorman, Anthony V.
    Heidenreich, Olaf
    Veal, Gareth J.
    van Delft, Frederik W.
    Lunec, John
    Irving, Julie A. E.
    LEUKEMIA, 2024, 38 (06) : 1223 - 1235
  • [6] Targeting the Wee1 Kinase for Treatment of Pediatric Down Syndrome Acute Myeloid Leukemia
    Caldwell, J. Timothy
    Edwards, Holly
    Buck, Steven A.
    Ge, Yubin
    Taub, Jeffrey W.
    PEDIATRIC BLOOD & CANCER, 2014, 61 (10) : 1767 - 1773
  • [7] Therapeutic targeting of mutated p53 in acute lymphoblastic leukemia
    van Leeuwen, Frank N.
    HAEMATOLOGICA, 2020, 105 (01) : 10 - 11
  • [8] TARGETING HISTONE DEACETYLASES (HDACS) AND WEE1 FOR TREATING HIGH-RISK NEUROBLASTOMA
    Hanmod, Santosh
    Wang, Guan
    Buck, Steven
    Wang, Zhihong
    Ge, Yubin
    PEDIATRIC BLOOD & CANCER, 2014, 61 : S62 - S62
  • [9] Targeting Histone Deacetylases (HDACs) and Wee1 for Treating High-Risk Neuroblastoma
    Hanmod, Santosh S.
    Wang, Guan
    Edwards, Holly
    Buck, Steven A.
    Ge, Yubin
    Taub, Jeffrey W.
    Wang, Zhihong
    PEDIATRIC BLOOD & CANCER, 2015, 62 (01) : 52 - 59
  • [10] Combined Inhibition of ChK1 and Wee1 As a New Therapeutic Strategy for High-Risk Multiple Myeloma Patients
    Bruyer, Angelique
    de Boussac, Hugues
    Martin, Thibaut
    Kassambara, Alboukadel
    Robert, Nicolas
    Cartron, Guillaume
    Hose, Dirk
    Seckinger, Anja
    Pasero, Philippe
    Moreaux, Jerome
    BLOOD, 2017, 130
12345